Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients Life Science Investing
Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts Life Science Investing
Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit Pharmaceutical Investing
Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting Pharmaceutical Investing
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries Life Science Investing
Systematic Review and Meta-Analysis of Real-World Observational Studies Provide Additional Evidence of Effectiveness of PREVYMIS in Preventing Cytomegalovirus Infection and Disease in Adults Undergoing Allogeneic HCT Life Science Investing
FDA Approves Merck's KEYTRUDA® for Patients With MSI?H/dMMR Advanced Endometrial Carcinoma, Who Have Disease Progression Following Prior Systemic Therapy in Any Setting and Are Not Candidates for Curative Surgery or Radiation Life Science Investing
AUPH INVESTOR NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting Pharmaceutical Investing
Bristol Myers Squibb to Demonstrate the Strength of its Growing Cardiovascular Portfolio at the American College of Cardiology's 71st Annual Scientific Session Pharmaceutical Investing
